Sood Manish M, Shafer Leigh Anne, Ho Julie, Reslerova Martina, Martinka Greg, Keenan Sean, Dial Sandra, Wood Gordon, Rigatto Claudio, Kumar Anand
Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
Section of Nephrology, University of Manitoba, Manitoba, Canada.
J Crit Care. 2014 Oct;29(5):711-7. doi: 10.1016/j.jcrc.2014.04.003. Epub 2014 Apr 18.
The fact that acute kidney injury (AKI) is associated with worse clinical outcomes forms the basis of most AKI prognostic scoring systems. However, early reversibility of renal dysfunction in acute illness is not considered in such systems. We sought to determine whether early (≤24 hours after shock documentation) reversibility of AKI was independently associated with in-hospital mortality in septic shock.
Patient information was derived from an international database of septic shock cases from 28 different institutions in Canada, the United States and Saudi Arabia. Data from a final cohort of 5443 patients admitted with septic shock between Jan 1996 and Dec 2009 was analyzed. The following 4 definitions were used in regards to AKI status: (1) reversible AKI = AKI of any RIFLE severity prevalent at shock diagnosis or incident at 6 hours post-diagnosis that reverses by 24 hours, (2) persistent AKI = AKI prevalent at shock diagnosis and persisting during the entire 24 hours post-shock diagnosis, (3) new AKI = AKI incident between 6 and 24 hours post-shock diagnosis, and (4) improved AKI = AKI prevalent at shock diagnosis or incident at 6 hours post followed by improvement of AKI severity across at least one RIFLE category over the first 24 hours. Cox proportional hazards were used to determine the association between AKI status and in-hospital mortality.
During the first 24 hours, reversible AKI occurred in 13.0%, persistent AKI in 54.9%, new AKI in 11.7%, and no AKI in 22.4%. In adjusted analyses, reversible AKI was associated with improved survival (HR, 0.64; 95% CI, 0.53-0.77) compared to no AKI (referent), persistent AKI (HR, 0.99; 95% CI, 0.88-1.11), and new AKI (HR, 1.41; 95% CI, 1.22-1.62). Improved AKI occurred in 19.1% with improvement across any RIFLE category associated with a significant decrease in mortality (HR, 0.53; 95% CI, 0.45-0.63). More rapid antimicrobial administration, lower Acute Physiology and Chronic Health Evaluation II score, lower age, and a smaller number of failed organs (excluding renal) on the day of shock as well as community-acquired infection were independently associated with reversible AKI.
In septic shock, reversible AKI within the first 24 hours of admission confers a survival benefit compared to no, new, or persistent AKI. Prognostic AKI classification schemes should consider integration of early AKI reversibility into the scoring system.
急性肾损伤(AKI)与更差的临床结局相关,这是大多数AKI预后评分系统的基础。然而,此类系统未考虑急性疾病中肾功能障碍的早期可逆性。我们试图确定AKI的早期(休克记录后≤24小时)可逆性是否与感染性休克患者的院内死亡率独立相关。
患者信息来自加拿大、美国和沙特阿拉伯28个不同机构的感染性休克病例国际数据库。分析了1996年1月至2009年12月期间收治的5443例感染性休克患者的最终队列数据。关于AKI状态使用了以下4种定义:(1)可逆性AKI = 休克诊断时存在的任何RIFLE严重程度的AKI或诊断后6小时发生且在24小时内逆转的AKI,(2)持续性AKI = 休克诊断时存在且在休克诊断后的整个24小时内持续存在的AKI,(3)新发AKI = 休克诊断后6至24小时发生的AKI,(4)改善性AKI = 休克诊断时存在的AKI或诊断后6小时发生的AKI,随后在最初24小时内AKI严重程度至少改善一个RIFLE类别。采用Cox比例风险模型确定AKI状态与院内死亡率之间的关联。
在最初24小时内,可逆性AKI发生率为13.0%,持续性AKI为54.9%,新发AKI为11.7%,无AKI为22.4%。在多因素分析中,与无AKI(参照组)、持续性AKI(风险比[HR],0.99;95%置信区间[CI],0.88 - 1.11)和新发AKI(HR,1.41;95% CI,1.22 - 1.62)相比,可逆性AKI与生存率改善相关(HR,0.64;95% CI,0.53 - 0.77)。改善性AKI发生率为19.1%,任何RIFLE类别改善均与死亡率显著降低相关(HR,0.53;95% CI,0.45 - 0.63)。抗菌药物给药更快、急性生理与慢性健康状况评分II更低、年龄更小、休克当天衰竭器官(不包括肾脏)数量更少以及社区获得性感染与可逆性AKI独立相关。
在感染性休克中,入院后最初24小时内的可逆性AKI与无AKI、新发AKI或持续性AKI相比具有生存获益。AKI预后分类方案应考虑将早期AKI可逆性纳入评分系统。